Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial

Table 4

Frequency of adverse events in each treatment group.

Adverse events	Diacerein ()	Placebo ()
Nausea	6 (17.1)	3 (8.3)	0.3
Vomiting	1 (2.9)	4 (11.1)	0.2
Diarrhea	10 (28.6)	6 (16.7)	0.2
Abdominal pain	4 (11.4)	4 (11.1)	1.0
Dark urine	21 (7.4)	8 (2.9)	0.001
Others	5 (14.3)	0	0.03

Data expressed as n (%).